Treatment of acute supratentorial ischemic stroke with abciximab is safe and may result in early neurological improvement. A preliminary report

Cerebrovasc Dis. 2004;18(3):249-50. doi: 10.1159/000080108. Epub 2004 Aug 6.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Abciximab
  • Antibodies, Monoclonal / therapeutic use*
  • Brain Ischemia / complications*
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use*
  • Nervous System / drug effects
  • Nervous System / physiopathology
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Severity of Illness Index
  • Stroke / drug therapy*
  • Stroke / etiology*
  • Stroke / physiopathology
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Abciximab